Wicker, no political naïf, brought out the big rhetorical ammo, reminding the senators that it was Jamie Thomson, the University of Wisconsin scientist who first reported isolating the cells in 1998, who said: «
If human embryonic stem cell research does not make you at least a bit uncomfortable, you have not thought about it enough.»
University of Wisconsin scientist, James A. Thomson, who first derived ESCs from embryos, has said «
if human embryonic stem cell research does not make you at least a little bit uncomfortable, you have not thought about it enough.»
Not exact matches
«It's an exciting development, and we await the outcome over the next year to see how well these
cells integrate, and
if there are any potential adverse reactions,» says Mike Cheetham of the Institute of Ophthalmology at University College London, one site where research is under way into a
human embryonic stem -
cell treatment for AMD.
«Even
if we can make other
cells to look like
embryonic stem cells, ES
cells allow you to investigate unique aspects of
human embryonic development.»
But
if homologous recombination could be worked out in
human (
embryonic)
stem cells, then cardiomyocytes with mutations in ion channels could be derived, as well as a large number of other very useful disease models of other tissues.
The finding could fundamentally change how we look at
human stem cell tech:
If chimeric monkeys require totipotent
cells before they can come into being, it stands to reason that
human embryonic stem cell therapy might also require totipotent
stem cells to render cures.
If that's the case, it is tempting to blame President George W. Bush's restrictions on research using
human embryonic stem cells (hESCs).
If dealing with the public relations nightmare over its on - off - on funding of Planned Parenthood wasn't enough, the Susan G. Komen for the Cure cancer charity last week also got entangled, somewhat bizarrely, in the debate over
human embryonic stem (ES)
cell research.
If I recall correctly, his paper had been published in Science, and it had been fast - tracked in what seemed transparently to be part of a political effort to sell the public on
human cloning to produce patient - specific
embryonic stem cells.
Anger about prospects for
human embryonic stem -
cell research might similarly attenuate
if practical applications emerge.
«
If we overcome the other obstacles, this approach could one day provide custom
human embryonic stem cells for use in therapy.»
The Society believes that research involving the transfer of a
human nucleus into an animal egg will lead to important new knowledge about
cell nuclear replacement (CNR) technology and,
if it were to prove possible to produce
embryonic stem cells by this route, would increase understanding of how to programme these
cells to develop into different tissue types.